Novel phthalimides regulating PD-1/PD-L1 interaction as potential immunotherapy agents

Novel phthalimides regulating PD-1/PD-L1 interaction as potential immunotherapy agents

Programmed cell death 1(PD-1)/programmed cell death ligand 1(PD-L1) have emerged as one of the most promising immune checkpoint targets for cancer immunotherapy. Despite the inherent advantages of small-molecule inhibitors over antibodies, the discovery of small-molecule inhibitors has fallen behind...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Chengliang Sun, Yao Cheng, Xiaojia Liu, Gefei Wang, Wenjian Min, Xiao Wang, Kai Yuan, Yi Hou, Jiaxing Li, Haolin Zhang, Haojie Dong, Liping Wang, Chenguang Lou, Yanze Sun, Xinmiao Yu, Hongbin Deng, Yibei Xiao, Peng Yang
التنسيق: مقال
اللغة:English
منشور في: Elsevier 2022-12-01
سلاسل:Acta Pharmaceutica Sinica B
الموضوعات:
PD-1/PD-L1
Small-molecule inhibitor
Immunotherapy
Co-crystal structure
الوصول للمادة أونلاين:http://www.sciencedirect.com/science/article/pii/S2211383522001770

الانترنت

http://www.sciencedirect.com/science/article/pii/S2211383522001770

مواد مشابهة